<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02694666</url>
  </required_header>
  <id_info>
    <org_study_id>514810</org_study_id>
    <nct_id>NCT02694666</nct_id>
  </id_info>
  <brief_title>Vibration Training for Preventing Falls in Healthy Population and Multiple Sclerosis</brief_title>
  <official_title>Effects of Controlled Whole-body Vibration Training on Preventing Falls Among Healthy Population and Ambulatory People With Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Georgia State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Georgia State University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to investigate the effects of controlled whole-body vibration training on
      reducing the likelihood of falls among healthy population and people with multiple sclerosis.
      (NOTE: research not covered by sponsored funding)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For each population, the participants will be randomized into two groups.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Real life falls</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Real life falls are monitored for 12 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Berg Balance Scale test</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>This test is used to assess the body balance skill in healthy elderly.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Slip-related falls on treadmill</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Participants will be exposed to unexpected slips during walking on a treadmill.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional mobility</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Functional mobility is measured by using the Timed-Up-and-Go test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensation</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Sensation is measured by nylon monofilaments kit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle strength</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Lower-limb joints' muscle strengths are evaluated by an isokinetic dynamometer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of motion</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>The range of motion of the lower limb joints are assessed by a goniometer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone density</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>The bone density of the heel bone is assessed by a bone ultrasonometer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multiple Sclerosis Functional Composite score</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>The Multiple Sclerosis Functional Composite score, which indicates the disability level in people with multiple sclerosis, is measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Equiscale balance test</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>This balance test is applied to individuals with multiple sclerosis to evaluate their body balance skill.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symbol Digit Modalities test</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>This test measures participants' attention and information processing speed and efficiency.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Selective Reminding test</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>This instrument assesses participants' verbal learning and memory capacity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavior Rating Inventory of Executive Function</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>This test is used to gauge one's everyday behaviors associated with specific domains of the executive functions.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">147</enrollment>
  <condition>Falls Prevention</condition>
  <arm_group>
    <arm_group_label>Vibration training group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The vibration group will receive 8-week controlled whole-body vibration training as the intervention on the Galileo Med L device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo training group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo group will receive 8-week placebo training on the Galileo Med L device</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Controlled whole-body vibration training</intervention_name>
    <description>The intervention is an 8-week program</description>
    <arm_group_label>Placebo training group</arm_group_label>
    <arm_group_label>Vibration training group</arm_group_label>
    <other_name>Vibration therapy; vibration training</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        For healthy population:

          -  Aged between 18 and 75

          -  No known history of musculoskeletal, neurological, cardiovascular, or pulmonary
             impairment

        For people with multiple sclerosis

          -  Self-reported multiple sclerosis and confirmed by the physician

          -  No significant relapse within the past 8 weeks

          -  To be able to walk independently a length of 25 feet

          -  Score on Patient Determined Disease Step &lt; 7

        Exclusion Criteria:

          -  Subjects use any sedative of any type.

          -  The heel bone density is less than -2.0
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Feng Yang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Georgia State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Georgia State University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>February 10, 2016</study_first_submitted>
  <study_first_submitted_qc>February 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 29, 2016</study_first_posted>
  <last_update_submitted>January 24, 2020</last_update_submitted>
  <last_update_submitted_qc>January 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Georgia State University</investigator_affiliation>
    <investigator_full_name>Feng Yang, PhD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

